These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12528314)

  • 1. CPI-1189. Centaur.
    Müller T
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1763-7. PubMed ID: 12528314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha infusion model for AIDS dementia complex.
    Bjugstad KB; Flitter WD; Garland WA; Philpot RM; Kirstein CL; Arendash GW
    J Neurovirol; 2000 Dec; 6(6):478-91. PubMed ID: 11175320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CPI-1189 inhibits interleukin 1beta-induced p38-mitogen-activated protein kinase phosphorylation: an explanation for its neuroprotective properties?
    Hensley K; Robinson KA; Pye QN; Floyd RA; Cheng I; Garland WA; Irwin I
    Neurosci Lett; 2000 Mar; 281(2-3):179-82. PubMed ID: 10704772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NXY-059. Centaur.
    Lapchak PA
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1758-62. PubMed ID: 12528313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment.
    Clifford DB; McArthur JC; Schifitto G; Kieburtz K; McDermott MP; Letendre S; Cohen BA; Marder K; Ellis RJ; Marra CM;
    Neurology; 2002 Nov; 59(10):1568-73. PubMed ID: 12451199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CPI-1189 attenuates effects of suspected neurotoxins associated with AIDS dementia: a possible role for ERK activation.
    Pulliam L; Irwin I; Kusdra L; Rempel H; Flitter WD; Garland WA
    Brain Res; 2001 Mar; 893(1-2):95-103. PubMed ID: 11222997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke.
    Maples KR; Green AR; Floyd RA
    CNS Drugs; 2004; 18(15):1071-84. PubMed ID: 15581379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NXY 059: CPI 22, NXY 059G.
    Adis International Ltd
    Drugs R D; 2003; 4(4):254-7. PubMed ID: 12848592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox nanoparticles: synthesis, properties and perspectives of use for treatment of neurodegenerative diseases.
    Sadowska-Bartosz I; Bartosz G
    J Nanobiotechnology; 2018 Nov; 16(1):87. PubMed ID: 30390681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel 1,4-benzoxazine compounds that are protective in tissue culture and in vivo models of neurodegeneration.
    Wang L; Ankati H; Akubathini SK; Balderamos M; Storey CA; Patel AV; Price V; Kretzschmar D; Biehl ER; D'Mello SR
    J Neurosci Res; 2010 Jul; 88(9):1970-84. PubMed ID: 20143421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel proteasome inhibitor BSc2118 protects against cerebral ischaemia through HIF1A accumulation and enhanced angioneurogenesis.
    Doeppner TR; Mlynarczuk-Bialy I; Kuckelkorn U; Kaltwasser B; Herz J; Hasan MR; Hermann DM; Bähr M
    Brain; 2012 Nov; 135(Pt 11):3282-97. PubMed ID: 23169919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperoside inhibits lipopolysaccharide-induced inflammatory responses in microglial cells via p38 and NFκB pathways.
    Fan HH; Zhu LB; Li T; Zhu H; Wang YN; Ren XL; Hu BL; Huang CP; Zhu JH; Zhang X
    Int Immunopharmacol; 2017 Sep; 50():14-21. PubMed ID: 28622577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carole Ho.
    Nat Rev Drug Discov; 2016 Nov; 15(12):816. PubMed ID: 27895326
    [No Abstract]   [Full Text] [Related]  

  • 16. 17,18-epoxyeicosatetraenoic acid targets PPARγ and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase.
    Morin C; Sirois M; Echavé V; Albadine R; Rousseau E
    Am J Respir Cell Mol Biol; 2010 Nov; 43(5):564-75. PubMed ID: 20008283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotrophic factors and neurodegenerative diseases: a delivery issue.
    Ruozi B; Belletti D; Bondioli L; De Vita A; Forni F; Vandelli MA; Tosi G
    Int Rev Neurobiol; 2012; 102():207-47. PubMed ID: 22748832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DBM1285 suppresses tumor necrosis factor alpha production by blocking p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2 signaling pathway.
    Kang JS; Kim HM; Choi IY; Han SB; Yoon YD; Lee H; Park KH; Cho IJ; Lee CW; Lee K; Lee KH; Park SK
    J Pharmacol Exp Ther; 2010 Aug; 334(2):657-64. PubMed ID: 20427474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
    Chen JF; Chern Y
    Handb Exp Pharmacol; 2011; (200):267-310. PubMed ID: 20859800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal Plants in Neurodegenerative Diseases: Perspective of Traditional Persian Medicine.
    Farzaei MH; Shahpiri Z; Mehri MR; Bahramsoltani R; Rezaei M; Raeesdana A; Rahimi R
    Curr Drug Metab; 2018; 19(5):429-442. PubMed ID: 29512453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.